Refining indications for contemporary surgical treatment of renal cell carcinoma metastatic to the pancreas.

about

Results of surgical management of renal cell carcinoma metastatic to the pancreas.Long-term survival after pancreatic resection for renal cell carcinoma metastasis.

P2860

Q35867326-C0E180B6-E5E9-43E9-995B-743266EF25A9 Q44382792-82DBF8D1-30D7-42E4-A563-9B1B89E7C732

P2860

Refining indications for contemporary surgical treatment of renal cell carcinoma metastatic to the pancreas.

Item

http://www.wikidata.org/entity/Q41409335

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Refining indications for conte ...... ma metastatic to the pancreas.

@en

type

Item

label

Refining indications for conte ...... ma metastatic to the pancreas.

@en

prefLabel

Refining indications for conte ...... ma metastatic to the pancreas.

@en

P1476

Refining indications for conte ...... ma metastatic to the pancreas.

@en

P2093

Aram N Demirjian

http://www.w3.org/2001/XMLSchema#string

Charles M Vollmer

http://www.w3.org/2001/XMLSchema#string

David F McDermott

http://www.w3.org/2001/XMLSchema#string

John T Mullen

http://www.w3.org/2001/XMLSchema#string

Mark P Callery

http://www.w3.org/2001/XMLSchema#string

Michael B Atkins

http://www.w3.org/2001/XMLSchema#string

P2860

Renal cell carcinoma metastatic to the pancreas: clinical and radiological features.

Renal cell carcinoma metastatic to the pancreas: a single-institution series and review of the literature.

Results after pancreatic resection for metastatic lesions.

High recurrence rate after atypical resection for pancreatic metastases from renal cell carcinoma.

Renal cell carcinoma: current status and future prospects.

Solitary and multiple isolated metastases of clear cell renal carcinoma to the pancreas: an indication for pancreatic surgery.

Pancreatic resection for metastatic renal cell carcinoma to the pancreas.

Treatment of metastatic renal cell carcinoma with a combination of bevacizumab and erlotinib.

Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma.

Synchronous pancreatic metastases from asymptomatic renal cell carcinoma.

P304

150-153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1477-2574.2009.00027.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26659650

http://www.w3.org/2001/XMLSchema#string

P698

19590640

http://www.w3.org/2001/XMLSchema#string

P921

Aizkuņģa dziedzeris

P932

2697876

http://www.w3.org/2001/XMLSchema#string

Refining indications for contemporary surgical treatment of renal cell carcinoma metastatic to the pancreas.

about

P2860

P2860

Refining indications for contemporary surgical treatment of renal cell carcinoma metastatic to the pancreas.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932